IriSys: Irisys' new liposomal anticancer drug delivery system receives US patent
Irisys, LLC, a provider of contract pharmaceutical development and manufacturing services, announced that it has been issued US Patent No. 11,033,530, Liposomal Anticancer Compositions. Irisys scientists
Read full article »
IRISYS is a California-based CDMO that provides services such as clinical development, product formulation and analytical support for the pharmaceutical industry.
Read more